Thrombosis, Deep Vein: Clinical Trials

5 trials for Thrombosis, Deep Vein, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 withdrawn. 1 Not applicable, 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 21Recruiting 1
Phase 41Recruiting 1

Follow Thrombosis, Deep Vein: new trials by email Literature Review of Thrombosis, Deep Vein trials Research Report on Thrombosis, Deep Vein

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)
standardized perioperative anticoagulation management Guideline - Thrombosis, Cancer
Not applicableRecruitingOttawa Hospital Research Institute7002026-05-052026-09-08
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
Perivascular dexamethasone, Perivascular sham - Thrombosis, Deep Vein, Iliofemoral; Thrombosis
Phase 2RecruitingMercator MedSystems, Inc.802021-10-292026-09-25
A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
Cerebral Stroke, Thrombosis, Deep Vein
WithdrawnPfizer2021-09-012021-11-22
A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment
Thrombosis, Deep Vein, Pulmonary Embolism
WithdrawnPfizer2021-08-232021-11-11
Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
enoxaparin or tinzaparin or dalteparin, No intervention - Liver Cancer, Surgery
Phase 4RecruitingHelsinki University Central Hospital10122021-02-102025-02-14

Narrower conditions

Venous Thrombosis (5)  ·  Pulmonary Embolism (3)  ·  Hemorrhage (2)  ·  Thrombosis (2)  ·  Atrial Fibrillation (1)  ·  Liver Neoplasms (1)  ·  Neoplasms (1)  ·  Stroke (1)

Broader conditions

Cardiovascular Diseases (5)  ·  Embolism and Thrombosis (5)  ·  Vascular Diseases (5)  ·  Embolism (3)  ·  Lung Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Thrombosis (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Arrhythmias, Cardiac (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)

Interventions

Dalteparin (1)  ·  Enoxaparin (1)  ·  Tinzaparin (1)

Sponsors

Pfizer (2)  ·  Helsinki University Central Hospital (1)  ·  Mercator MedSystems, Inc. (1)  ·  Ottawa Hospital Research Institute (1)

Countries

Canada (1)  ·  Finland (1)  ·  Ireland (1)  ·  Norway (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Joseph Shaw, MD, MSc, FRCPC (1)

NIH funding

R44HL160434 (1)